Authors:
Dovey, HF
John, V
Anderson, JP
Chen, LZ
Andrieu, PD
Fang, LY
Freedman, SB
Folmer, B
Goldbach, E
Holsztynska, EJ
Hu, KL
Johnson-Wood, KL
Kennedy, SL
Kholedenko, D
Knops, JE
Latimer, LH
Lee, M
Liao, Z
Lieberburg, IM
Motter, RN
Mutter, LC
Nietz, J
Quinn, KP
Sacchi, KL
Seubert, PA
Shopp, GM
Thorsett, ED
Tung, JS
Wu, J
Yang, S
Yin, CT
Schenk, DB
May, PC
Altstiel, LD
Bender, MH
Boggs, LN
Britton, TC
Clemens, JC
Czilli, DL
Dieckman-McGinty, DK
Droste, JJ
Fuson, KS
Gitter, BD
Hyslop, PA
Johnstone, EM
Li, WY
Little, SP
Mabry, TE
Miller, FD
Ni, B
Nissen, JS
Porter, WJ
Potts, BD
Reel, JK
Stephenson, D
Su, Y
Shipley, LA
Whitesitt, CA
Yin, T
Audia, JE
Citation: Hf. Dovey et al., Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain, J NEUROCHEM, 76(1), 2001, pp. 173-181
Authors:
Zarrinmayeh, H
Zimmerman, DM
Cantrell, BE
Schober, DA
Bruns, RF
Gackenheimer, SL
Ornstein, PL
Hipskind, PA
Britton, TC
Gehlert, DR
Citation: H. Zarrinmayeh et al., Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists, BIOORG MED, 9(5), 1999, pp. 647-652
Authors:
Britton, TC
Spinazze, PG
Hipskind, PA
Zimmerman, DM
Zarrinmayeh, H
Schober, DA
Gehlert, DR
Bruns, RF
Citation: Tc. Britton et al., Structure-activity relationships of a series of benzothiophene-derived NPYY1 antagonists: Optimization of the C-2 side chain, BIOORG MED, 9(3), 1999, pp. 475-480